Evidence map›Paper›PMID 36551370›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Chemical Composition and In Vitro and In Silico Antileishmanial Evaluation of the Essential Oil from

Jesús García-Díaz, Julio César Escalona-Arranz, Ania Ochoa-Pacheco, Sócrates Golzio Dos Santos, Rosalia González-Fernández, Julio Alberto Rojas-Vargas, Lianet Monzote, William N Setzer

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Promising Antileishmanial Activity ofMolecules (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Chemistry and Bioactivity ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Jesús García-DíazPharmacy Department, Natural and Exacts Sciences Faculty, Oriente University, Avenida Patricio Lumumba s/n, Santiago de Cuba 90500, Cuba.ORCID 0000-0003-2309-3417
Julio César Escalona-ArranzPharmacy Department, Natural and Exacts Sciences Faculty, Oriente University, Avenida Patricio Lumumba s/n, Santiago de Cuba 90500, Cuba.ORCID 0000-0003-3609-4451
Ania Ochoa-PachecoPharmacy Department, Natural and Exacts Sciences Faculty, Oriente University, Avenida Patricio Lumumba s/n, Santiago de Cuba 90500, Cuba.
Sócrates Golzio Dos SantosDepartment of Pharmaceutical Sciences, Federal University of Paraiba, João Pessoa 58059-900, Brazil.ORCID 0000-0002-8458-8731
Rosalia González-FernándezToxicology and Biomedicine Centre (TOXIMED), University of Medical Science, Autopista Nacional Km 1½ s/n, Santiago de Cuba 90400, Cuba.
Julio Alberto Rojas-VargasChemistry Department, Natural and Exacts Sciences Faculty, Oriente University, Avenida Patricio Lumumba s/n, Santiago de Cuba 90500, Cuba.
Lianet MonzoteDepartment of Parasitology, Institute of Tropical Medicine "Pedro Kourí", Apartado Postal No. 601, Marianao 13, La Habana 10400, Cuba.ORCID 0000-0002-1958-809X
William N SetzerResearch Network Natural Products against Neglected Diseases (ResNetNPND).ORCID 0000-0002-3639-0528
Universidad de Oriente · CUDrugs for Neglected Diseases Initiative · CHUniversidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Croton linearisepi-γ-eudesmolessential oilLeishmania amazonensis

Identifiers

PMID36551370
PMCPMC9774621
OpenAlexW4310213917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.